| Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer T Tomonaga, K Matsushita, S Yamaguchi, T Oohashi, H Shimada, ... Cancer research 63 (13), 3511-3516, 2003 | 355 | 2003 |
| Plectin promotes migration and invasion of cancer cells and is a novel prognostic marker for head and neck squamous cell carcinoma K Katada, T Tomonaga, M Satoh, K Matsushita, Y Tonoike, Y Kodera, ... Journal of proteomics 75 (6), 1803-1815, 2012 | 184 | 2012 |
| Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis T Tomonaga, K Matsushita, S Yamaguchi, M Oh-Ishi, Y Kodera, T Maeda, ... Clinical cancer research 10 (6), 2007-2014, 2004 | 178 | 2004 |
| Centromere protein H is up-regulated in primary human colorectal cancer and its overexpression induces aneuploidy T Tomonaga, K Matsushita, M Ishibashi, M Nezu, H Shimada, T Ochiai, ... Cancer research 65 (11), 4683-4689, 2005 | 156 | 2005 |
| Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration K Hirose, M Hakozaki, Y Nyunoya, Y Kobayashi, K Matsushita, ... British journal of cancer 72 (3), 708-714, 1995 | 132 | 1995 |
| Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin T Nishimori, T Tomonaga, K Matsushita, M Oh‐Ishi, Y Kodera, T Maeda, ... Proteomics 6 (3), 1011-1018, 2006 | 118 | 2006 |
| Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan T Kageyama, K Ikeda, S Tanaka, T Taniguchi, H Igari, Y Onouchi, ... Clinical Microbiology and Infection 27 (12), 1861. e1-1861. e5, 2021 | 112 | 2021 |
| Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories T Ishige, S Murata, T Taniguchi, A Miyabe, K Kitamura, K Kawasaki, ... Clinica Chimica Acta 507, 139-142, 2020 | 108 | 2020 |
| An essential role of alternative splicing of c-myc suppressor FUSE-binding protein–interacting repressor in carcinogenesis K Matsushita, T Tomonaga, H Shimada, A Shioya, M Higashi, ... Cancer research 66 (3), 1409-1417, 2006 | 104 | 2006 |
| YKL-40 identified by proteomic analysis as a biomarker of sepsis N Hattori, S Oda, T Sadahiro, M Nakamura, R Abe, K Shinozaki, ... Shock 32 (4), 393-400, 2009 | 92 | 2009 |
| Proteomic analysis of gingival crevicular fluid for discovery of novel periodontal disease markers S Tsuchida, M Satoh, H Umemura, K Sogawa, Y Kawashima, S Kado, ... Proteomics 12 (13), 2190-2202, 2012 | 90 | 2012 |
| Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase M Seimiya, T Tomonaga, K Matsushita, M Sunaga, M Oh‐ishi, Y Kodera, ... Hepatology 48 (2), 519-530, 2008 | 90 | 2008 |
| Strong HLA‐DR antigen expression on cancer cells relates to better prognosis of colorectal cancer patients: Possible involvement of c‐myc suppression by interferon‐γin situ K Matsushita, T Takenouchi, H Shimada, T Tomonaga, H Hayashi, ... Cancer science 97 (1), 57-63, 2006 | 89 | 2006 |
| Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring and tissue microarray analysis. TT Kume H, Muraoka S, Kuga T, Adachi J, Narumi R Mol Cell Proteomics, 2014 | 88 | 2014 |
| NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers Y Oshima, H Shimada, S Yajima, T Nanami, K Matsushita, F Nomura, ... Journal of gastroenterology 51, 30-34, 2016 | 76 | 2016 |
| Moesin is a possible target molecule for cytomegalovirus-related Guillain-Barré syndrome. KS Sawai S, Satoh M, Mori M, Misawa S, Sogawa K, Kazami T, Ishibashi M ... Neurology., pii: 10.1212/WNL.0000000, 2014 | 70* | 2014 |
| Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells S Kagawa, S Takano, H Yoshitomi, F Kimura, M Satoh, H Shimizu, ... journal of surgical research 178 (2), 758-767, 2012 | 69 | 2012 |
| Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells I Hoshino, H Matsubara, N Hanari, M Mori, T Nishimori, Y Yoneyama, ... Clinical cancer research 11 (21), 7945-7952, 2005 | 67 | 2005 |
| Application of quantitative proteomic analysis using tandem mass tags for discovery and identification of novel biomarkers in periodontal disease S Tsuchida, M Satoh, Y Kawashima, K Sogawa, S Kado, S Sawai, ... Proteomics 13 (15), 2339-2350, 2013 | 59 | 2013 |
| Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes Y Suzuki, K Matsushita, M Seimiya, T Yoshida, Y Sawabe, M Ogawa, ... Clinical Chemistry and Laboratory Medicine 50 (10), 1833-1839, 2012 | 55 | 2012 |
HIDEAKI SHIMADAProfessor of Surgery, Toho University School of MedicineVerified email at med.toho-u.ac.jp
